{
  "docId": "019de516-48a5-7631-970d-a6192a59c040",
  "docSlug": "5b4cac48a3342d745accb48141e027b4",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 39,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-48a5-7631-970d-a6192a59c040/16",
  "deckHref": "/decks/019de516-48a5-7631-970d-a6192a59c040",
  "deckJsonHref": "/decks/019de516-48a5-7631-970d-a6192a59c040.json",
  "deckAnchorHref": "/decks/019de516-48a5-7631-970d-a6192a59c040#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.52,
        "w": 0.28,
        "x": 0.11,
        "y": 0.22
      },
      "kind": "image",
      "text": "Miebo™ (perfluorohexyloctane ophthalmic solution) product packaging",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0935177-79c8-4ba3-9b23-78b1ff896917",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.46,
        "x": 0.44,
        "y": 0.24
      },
      "kind": "list",
      "text": "CRITICAL SUCCESS FACTORS\nGrow the market by educating HCPs on disease etiology and difference between treatment modalities\nEstablish MIEBO™ as the first and only therapeutic to address evaporative dry eye\nProvide broad and reliable access, reimbursement and affordability for patients\nEnsure best-in-class field force effectiveness\nEngage KOLs² within Ophthalmology and Optometry\nExpand on scientific evidence to strengthen differentiation\nEnsure timely and reliable supply",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70d2a96e-a5e6-4297-9c4d-5c4d6e255d50",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.31,
        "x": 0.08,
        "y": 0.78
      },
      "kind": "paragraph",
      "text": "U.S. launch expected: 3Q23",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e03b6616-05ae-4e5d-abd3-d6bb1f59a90b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.31,
        "x": 0.16,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. See Slide 1 for further information on forward-looking information.\n2. Key opinion leaders.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f897f76e-f6d1-443c-891f-2048158c0721",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.63,
        "x": 0.045,
        "y": 0.08
      },
      "kind": "title",
      "text": "MIEBO™: Approved and Launching Soon¹",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "52ccbb49-07f5-4a41-8112-9bf4743b98dc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem-Agitate-Solve (PAS)",
      "slug": "problem-agitate-solve-pas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "10de02bb-3c49-4a9d-9634-7b3af7ca9d12",
      "evidence": "The slide presents a solution (MIEBO) and its critical success factors, which implies a problem to be solved.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 14,
      "beatId": "83fb7e88-f765-459a-865d-12d458331d10",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The company outlines its plans for future growth and provides additional information.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 15,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "2cc7dd0e-6d75-4982-adee-b82919e85848",
      "evidence": "Bausch + Lomb outlines its plans for investing in launch excellence and driving growth.",
      "position": 1,
      "objective": "What are the potential outcomes of investing in launch excellence and driving growth in the surgical portfolio?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}